115 related articles for article (PubMed ID: 38489009)
1. Appraisal of Chitosan-Coated Lipid Nano-Combination with Miltefosine and Albendazole in the Treatment of Murine Trichinellosis: Experimental Study with Evaluation of Immunological and Immunohistochemical Parameters.
Ibrahim AF; Selim SM; Shafey DA; Sweed DM; Farag SA; Gouda MA
Acta Parasitol; 2024 Mar; 69(1):929-950. PubMed ID: 38489009
[TBL] [Abstract][Full Text] [Related]
2. Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis.
Eid RK; Ashour DS; Essa EA; El Maghraby GM; Arafa MF
Carbohydr Polym; 2020 Mar; 232():115826. PubMed ID: 31952620
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the potential prophylactic and therapeutic effects of kaempferol on experimental
Abo Maged AI; Metwally KM; El-Menyawy HM; Hegab F; El-Wakil ES
J Helminthol; 2023 Apr; 97():e36. PubMed ID: 37070392
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic efficacy of albendazole and berberine loaded on bovine serum albumin nanoparticles on intestinal and muscular phases of experimental trichinellosis.
El-Wakil ES; Khodear GAM; Ahmed HES; Ibrahim GIK; Hegab F; Abdo SM
Acta Trop; 2023 May; 241():106896. PubMed ID: 36921748
[TBL] [Abstract][Full Text] [Related]
5. In vitro evaluation of albendazole-loaded nanostructured lipid carriers on Echinococcus granulosus microcysts and their prophylactic efficacy on experimental secondary hydatidosis.
Farhadi M; Haniloo A; Rostamizadeh K; Ahmadi N
Parasitol Res; 2021 Dec; 120(12):4049-4060. PubMed ID: 34669034
[TBL] [Abstract][Full Text] [Related]
6. Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.
Kang BS; Choi JS; Lee SE; Lee JK; Kim TH; Jang WS; Tunsirikongkon A; Kim JK; Park JS
Carbohydr Polym; 2017 Mar; 159():39-47. PubMed ID: 28038752
[TBL] [Abstract][Full Text] [Related]
7. Oxidative stress mediated apoptotic potential of mefloquine on experimental trichinellosis.
Elmehy DA; Ismail HIH; Soliman NA; Amer BS; Elkaliny HH; El-Ebiary AA; Gamea GA
Acta Trop; 2021 Jan; 213():105760. PubMed ID: 33221280
[TBL] [Abstract][Full Text] [Related]
8. Trichinella spiralis: A new parasitic target for curcumin nanoformulas in mice models.
Khedr SI; Gomaa MM; Mogahed NMFH; Gamea GA; Khodear GAM; Sheta E; Soliman NAH; El Saadany AA; Salama AM
Parasitol Int; 2024 Feb; 98():102810. PubMed ID: 37730195
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni.
Eissa MM; El-Azzouni MZ; El-Khordagui LK; Abdel Bary A; El-Moslemany RM; Abdel Salam SA
Acta Trop; 2020 Dec; 212():105714. PubMed ID: 32950482
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Albendazole-Chitosan Microsphere-based Treatment for Alveolar Echinococcosis in Mice.
Abulaihaiti M; Wu XW; Qiao L; Lv HL; Zhang HW; Aduwayi N; Wang YJ; Wang XC; Peng XY
PLoS Negl Trop Dis; 2015; 9(9):e0003950. PubMed ID: 26352932
[TBL] [Abstract][Full Text] [Related]
11. Novel albendazole formulations given during the intestinal phase of Trichinella spiralis infection reduce effectively parasitic muscle burden in mice.
García A; Barrera MG; Piccirilli G; Vasconi MD; Di Masso RJ; Leonardi D; Hinrichsen LI; Lamas MC
Parasitol Int; 2013 Dec; 62(6):568-70. PubMed ID: 23993995
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the efficacy of albendazole sulfoxide (ABZ-SO)-loaded chitosan-PLGA nanoparticles in the treatment of cystic echinococcosis in laboratory mice.
Darvishi MM; Moazeni M; Alizadeh M; Abedi M; Tamaddon AM
Parasitol Res; 2020 Dec; 119(12):4233-4241. PubMed ID: 32996050
[TBL] [Abstract][Full Text] [Related]
13. Novel albendazole-chitosan nanoparticles for intestinal absorption enhancement and hepatic targeting improvement in rats.
Liu Y; Wang XQ; Ren WX; Chen YL; Yu Y; Zhang JK; Bawudong D; Gu JP; Xu XD; Zhang XN
J Biomed Mater Res B Appl Biomater; 2013 Aug; 101(6):998-1005. PubMed ID: 23529958
[TBL] [Abstract][Full Text] [Related]
14. Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice.
Lopez-Garcia ML; Torrado-Duran S; Torrado-Duran J; Martínez-Fernández AR; Bolás-Fernández F
Int J Parasitol; 1997 Jul; 27(7):781-5. PubMed ID: 9279580
[TBL] [Abstract][Full Text] [Related]
15. The effect of intestinal trichinellosis on oral bioavailability of albendazole in mice.
Rodríguez JJ; de Prada I; Durán JJ; Fernández FB
Parasitol Res; 2009 Jul; 105(1):65-70. PubMed ID: 19241092
[TBL] [Abstract][Full Text] [Related]
16. Preparation, Pharmacokinetics, and Antitumor Potential of Miltefosine-Loaded Nanostructured Lipid Carriers.
Yu G; Ali Z; Sajjad Khan A; Ullah K; Jamshaid H; Zeb A; Imran M; Sarwar S; Choi HG; Ud Din F
Int J Nanomedicine; 2021; 16():3255-3273. PubMed ID: 34012260
[TBL] [Abstract][Full Text] [Related]
17. Antihelminthic and antiangiogenic effects of zinc oxide nanoparticles on intestinal and muscular phases of trichinellosis.
Ashoush SE; Soliman EK
J Helminthol; 2023 Jul; 97():e56. PubMed ID: 37462419
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery.
Noor NM; Sheikh K; Somavarapu S; Taylor KMG
Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472
[TBL] [Abstract][Full Text] [Related]
19. Egyptian propolis and selenium nanoparticles against murine trichinosis: a novel therapeutic insight.
Sarhan MH; Farghaly A; Abd El-Aal NF; Mohammed Farag S; Ahmed Ali A; Farag TI
J Helminthol; 2022 Jul; 96():e50. PubMed ID: 35856263
[TBL] [Abstract][Full Text] [Related]
20. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole.
García JJ; Bolás F; Torrado JJ
Int J Pharm; 2003 Jan; 250(2):351-8. PubMed ID: 12527162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
